M. Nishitani

发表

Expression of angiopoietin‐1 and ‐2, and its clinical significance in human bladder cancer

Masayuki Takahashi, H. Kanayama, S. Kagawa, 2005, BJU international.

Phase I trial of personalized peptide vaccination for cytokine‐refractory metastatic renal cell carcinoma patients

H. Kanayama, K. Itoh, A. Yamada, 2007, Cancer science.

Long-term outcomes of the Japanese hemodialysis patients with prostate cancer detected by prostate-specific antigen screening.

J. Minakuchi, Masayuki Takahashi, H. Kanayama, 2021, The journal of medical investigation : JMI.

Changes in levels of prostate-specific antigen and testosterone following discontinuation of long-term hormone therapy for non-metastatic prostate cancer.

Masayuki Takahashi, H. Kanayama, K. Yamaguchi, 2000, The journal of medical investigation : JMI.

Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.

S. Kagawa, M. Nishitani, S. Kagawa, 1998, Urology.

[Analysis of serum soluble interferon alpha/beta receptor levels in patients with urological diseases].

S. Kagawa, M. Nishitani, M. Takahashi, 2000, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells

J. Miyazaki, H. Kanayama, S. Kagawa, 2002, Cancer Gene Therapy.

Role of phosphatidylinositol‐3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor‐related apoptosis‐inducing ligand

Masayuki Takahashi, H. Kanayama, H. Izaki, 2006, Cancer science.

Indications for laparoscopic adrenalectomy for non‐functional adrenal tumor with hypertension: Usefulness of adrenocortical scintigraphy

Masayuki Takahashi, H. Kanayama, H. Izaki, 2006, International journal of urology : official journal of the Japanese Urological Association.

Expression of angiostatin cDNA in a murine renal cell carcinoma suppresses tumor growth in vivo.

T. Naroda, H. Kanayama, S. Kagawa, 2002, Urology.

Reduction or Discontinuation of Antibiotic Prophylaxis in Vascular Access Surgery, Tendon Sheath Incision and PD Catheter Placement

K. Nagai, J. Minakuchi, H. Kanayama, 2015, The journal of vascular access.

Prognostic significance of matrix metalloproteinases‐2 activation ratio in renal cell carcinoma

T. Naroda, Masayuki Takahashi, H. Kanayama, 2002, International journal of urology : official journal of the Japanese Urological Association.

Cytokine gene therapy for cancer with naked DNA.

S. Kagawa, S. Kagawa, K. Himeno, 2000, Molecular urology.

[Ectopic prostatic tissue in retrotrigone of the bladder: a case report].

S. Kagawa, M. Nishitani, Y. Yamamoto, 2001, Hinyokika kiyo. Acta urologica Japonica.

Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor.

Masayuki Takahashi, H. Kanayama, T. Fukumori, 2007, Urology.

Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder

K. Toida, H. Kanayama, T. Fukumori, 2006, BJU international.

[High flow priapism after perineal trauma, successfully treated by unilateral embolization of the internal pudendal artery: a case report].

K. Nakamura, M. Nishitani, K. Ohta, 1995, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Clinical research of renal vein control using Hem‐o‐lok clips in laparoscopic nephrectomy

Masayuki Takahashi, H. Kanayama, H. Izaki, 2006, International journal of urology : official journal of the Japanese Urological Association.

Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.

Y. Baba, Y. Shinohara, M. Ishikawa, 2006, Urologic oncology.

Peritoneo-caval shunt after reinfusion treatment with cell-free and concentrated autogenous ascitic fluid in patients with intractable ascites

M. Kuwahara, M. Nishitani, K. Ohta, 1994 .

Prognostic values of matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 expression in bladder cancer

H. Kanayama, S. Kagawa, Yasushi Kurokawa, 1998 .

Association Between Interdialytic Weight Gain, Perception About Dry Weight, and Dietary and Fluid Behaviors Based on Body Mass Index Among Patients on Hemodialysis.

T. Kinoshita, R. Akamatsu, M. Nishitani, 2019, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.

H. Kanayama, S. Kagawa, Y. Kurokawa, 1998, Cancer.

Strategy for Repeat Prostate Biopsy: Predictors of Positive Biopsy and Additional Biopsy Location

Masayuki Takahashi, H. Kanayama, H. Izaki, 2008, Urologia Internationalis.

Pulmonary sarcoidosis as a cause of intermittent fever of unknown origin in a hemodialysis patient with renal cell carcinoma: A case report and literature review

Hisato Shima, M. Tashiro, Tomoko Inoue, 2019, Hemodialysis international. International Symposium on Home Hemodialysis.

Successful treatment of direct hemoperfusion with polymyxin B-immobilized fiber for septic shock and severe acute kidney injury due to ceftriaxone-resistant Escherichia coli: a case report with literature review

Hisato Shima, M. Tashiro, Tomoko Inoue, 2020, Renal Replacement Therapy.

Expression of vascular endothelial growth factor isoforms and platelet-derived endothelial cell growth factor in bladder cancer.

Kanda, T. Fukumori, M. Nishitani, 2000, Urologic oncology.